Works matching Epstein-Barr virus vaccine
Results: 55
Exploring the nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine candidate against Epstein Barr virus.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66828-x
- By:
- Publication type:
- Article
Issues related to development of Epstein-Barr virus vaccines.
- Published in:
- 1996
- By:
- Publication type:
- Editorial
Immunoinformatic Execution and Design of an Anti-Epstein–Barr Virus Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses.
- Published in:
- Microorganisms, 2023, v. 11, n. 10, p. 2448, doi. 10.3390/microorganisms11102448
- By:
- Publication type:
- Article
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 107, p. 1, doi. 10.1126/scitranslmed.3002878
- By:
- Publication type:
- Article
Vaccine strategies against Epstein-Barr virus-associated disease: lessons from studies on cytotoxic T-cell-mediated immune regulation.
- Published in:
- Immunological Reviews, 1999, v. 170, n. 1, p. 49, doi. 10.1111/j.1600-065X.1999.tb01328.x
- By:
- Publication type:
- Article
Hypersensitivity to influenza vaccine in a case of Epstein- Barr virus-associated T-lymphoproliferative disorder.
- Published in:
- British Journal of Dermatology, 2015, v. 172, n. 6, p. 1686, doi. 10.1111/bjd.13713
- By:
- Publication type:
- Article
A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 643, p. 1, doi. 10.1126/scitranslmed.abf3685
- By:
- Publication type:
- Article
Design of a multi-epitopic vaccine against Epstein-Barr virus via computer-based methods.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1115345
- By:
- Publication type:
- Article
Validation of a first-generation epstein-barr virus vaccine preparation suitable for human use.
- Published in:
- Journal of Medical Virology, 1989, v. 29, n. 1, p. 74, doi. 10.1002/jmv.1890290114
- By:
- Publication type:
- Article
Liposomal subunit vaccine against Epstein-Barr virus-induced malignant lymphoma.
- Published in:
- Nature, 1986, v. 320, n. 6057, p. 87, doi. 10.1038/320087b0
- By:
- Publication type:
- Article
Epstein - Barr virus: Dream or reality of a vaccine?
- Published in:
- Nature, 1985, v. 318, n. 6043, p. 230, doi. 10.1038/318230a0
- By:
- Publication type:
- Article
Urgency and necessity of Epstein-Barr virus prophylactic vaccines.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00587-6
- By:
- Publication type:
- Article
Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.701611
- By:
- Publication type:
- Article
Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ВАКСИНИ ЗА ПРОФИЛАКТИКА НА ЕПЩАЙН-БАР ВИРУС
- Published in:
- Medical Review / Meditsinski Pregled, 2018, v. 54, n. 6, p. 15
- By:
- Publication type:
- Article
Construction and humoral immune response of Epstein-Barr virus latent membrane protein 2 DNA vaccine in mice.
- Published in:
- Frontiers of Medicine in China, 2009, v. 3, n. 4, p. 390, doi. 10.1007/s11684-009-0087-5
- By:
- Publication type:
- Article
GB and gH/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection.
- Published in:
- Archives of Virology, 2024, v. 169, n. 8, p. 1, doi. 10.1007/s00705-024-06095-3
- By:
- Publication type:
- Article
Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 169, doi. 10.3390/vaccines8020169
- By:
- Publication type:
- Article
Specific cellular immune responses in mice immunized with DNA, adeno-associated virus and adenoviral vaccines of Epstein-Barr virus-LMP2 alone or in combination.
- Published in:
- SCIENCE CHINA Life Sciences, 2011, v. 54, n. 3, p. 263, doi. 10.1007/s11427-011-4147-0
- By:
- Publication type:
- Article
Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pan-genome and reverse vaccinology approaches to design multi-epitope vaccine against Epstein-Barr virus associated with colorectal cancer.
- Published in:
- Immunologic Research, 2023, v. 71, n. 6, p. 887, doi. 10.1007/s12026-023-09403-2
- By:
- Publication type:
- Article
Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein-Barr virus (EBV).
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37070-z
- By:
- Publication type:
- Article
Recombinant gp35 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and effiacy of an Epstein-Barr virus vaccine in health young adults.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Epstein-barr virus vaccine for the prevention of infectious mononucleosis -- and what else?
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Epstein-Barr Virus Vaccine for the Prevention of Infectious Mononucleosis-and What Else?
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein-Barr Virus Vaccine in Healthy Young Adults.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 12, p. 1749, doi. 10.1086/523813
- By:
- Publication type:
- Article
mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 20, p. 13054, doi. 10.3390/ijerph192013054
- By:
- Publication type:
- Article
Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus.
- Published in:
- Applied Microbiology & Biotechnology, 2016, v. 100, n. 3, p. 1221, doi. 10.1007/s00253-015-7027-x
- By:
- Publication type:
- Article
In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4.
- Published in:
- European Journal of Immunology, 1988, v. 18, n. 11, p. 1689, doi. 10.1002/eji.1830181106
- By:
- Publication type:
- Article
Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals.
- Published in:
- Clinical & Experimental Immunology, 1986, v. 63, n. 2, p. 485
- By:
- Publication type:
- Article
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 540, doi. 10.3390/vaccines11030540
- By:
- Publication type:
- Article
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.734471
- By:
- Publication type:
- Article
The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.677027
- By:
- Publication type:
- Article
CD40L-adjuvanted DNA vaccine carrying EBV-LMP2 antigen enhances anti-tumor effect in NPC transplantation tumor animal.
- Published in:
- Central European Journal of Immunology, 2018, v. 43, n. 2, p. 117, doi. 10.5114/ceji.2018.77379
- By:
- Publication type:
- Article
Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 12, p. 1930, doi. 10.3390/v16121930
- By:
- Publication type:
- Article
Screening for Epstein-Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Use of CD107-based cell sorting ex vivo to enrich subdominant CD8<sup>+</sup> T cells in culture.
- Published in:
- Immunology & Cell Biology, 2007, v. 85, n. 7, p. 546, doi. 10.1038/sj.icb.7100083
- By:
- Publication type:
- Article
Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 7, p. 983, doi. 10.3390/biology12070983
- By:
- Publication type:
- Article
Role of BamHI-A Rightward Frame 1 in Epstein–Barr Virus-Associated Epithelial Malignancies.
- Published in:
- Biology (2079-7737), 2020, v. 9, n. 12, p. 461, doi. 10.3390/biology9120461
- By:
- Publication type:
- Article
A Cohort Study among University Students: Identification of Risk Factors for Epstein-Barr Virus Seroconversion and Infectious Mononucleosis.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 3, p. 276, doi. 10.1086/505400
- By:
- Publication type:
- Article
Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 5, p. 1993, doi. 10.1093/brain/awac401
- By:
- Publication type:
- Article
Cytomegalovirus and Epstein–Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 35, doi. 10.3390/vaccines8010035
- By:
- Publication type:
- Article
Herpesvirus Vaccines: An Update.
- Published in:
- BioDrugs, 1998, v. 10, n. 4, p. 257, doi. 10.2165/00063030-199810040-00001
- By:
- Publication type:
- Article
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39770-1
- By:
- Publication type:
- Article
A vaccine to kiss EBV goodbye.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 489, p. N.PAG, doi. 10.1126/scitranslmed.aax1729
- By:
- Publication type:
- Article
Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals vaccinated with recombinant hepatitis B surface antigen.
- Published in:
- Immunology, 2001, v. 104, n. 1, p. 75, doi. 10.1046/j.1365-2567.2001.01273.x
- By:
- Publication type:
- Article
Vaccine development/Prion disease/Viral-induced tumours.
- Published in:
- Journal of NeuroVirology, 2002, v. 8, p. 53, doi. 10.1080/13550280290050037
- By:
- Publication type:
- Article